Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Night Work Hours Reduction Trial (WHRedu)

23 de setembro de 2026 atualizado por: Finnish Institute of Occupational Health

Trial of Reduced Working Hours Among Regular Night Shift Workers in Public Health and Social Care

The primary aim of this study is to investigate the effects of reducing weekly working hours among employees working night shifts regularly from 38 hours 15 minutes to 36 hours on payroll-based, objective working-hour characteristics, sickness absence, and workforce retention. The secondary aim is to investigate experiences of promoting and hindering factors related to the working-hour reduction, its implementation process, and perceived benefits and challenges.

The working-hour reduction will be implemented in three Finnish wellbeing services counties with different starting dates, the first being in late September 2026 and the latest in early 2027. The working-hour reduction has been agreed upon by the parties to the collective agreement for Finnish public social and health care. Thus, intervention is a so-called natural experiment in a real-life setting.

The effects of the intervention will be evaluated using a quasi-experimental design with staggered, non-randomized implementation across participating counties. Administrative, payroll-based, employer-owned working-hour data, including records of sickness absences without any medical or health information and other absences (including unpaid, education, and childcare), will be used to compare changes before and during the intervention among work units participating in the working-hour reduction. The investigation will also utilize matched work units that do not participate in the reduction (i.e., intervention) as control units (i.e., continuing standard working-hour arrangements).

Visão geral do estudo

Status

Ainda não está recrutando

Condições

Intervenção / Tratamento

Descrição detalhada

Introduction Night work is associated with increased fatigue, impaired recovery, sickness absence, and difficulties in maintaining long-term work ability (Kecklund & Axelsson, 2016; Krutova et al., 2022). In addition, night work has been classified as probably carcinogenic to humans (IARC Working Group on the Identification of Carcinogenic Hazards to Humans, 2020). One potential strategy for reducing the burden associated with night work is to decrease total working hours while maintaining service quality and workforce availability. Although organizations have experimented with reduced working hours (Hanbury et al., 2023; Neubert et al., 2022; Voglino et al., 2022) detailed examination of large-scale workplace interventions for the effects of working-hour reduction among night workers using administrative, payroll-based working-hour data remains very limited.

The present study evaluates a reduction in weekly working hours from 38 hours 15 minutes to 36 hours among employees working night shifts in Finnish wellbeing services counties using administrative, payroll-based, employer-owned working-hour data (see e.g., Härmä et al., 2015; Härmä et al., 2025; Ropponen et al., 2024).

Intervention The natural experiment of working hour reduction, later referred to as the intervention, consists of reducing contractual weekly working hours from 38 hours 15 minutes to 36 hours among employees working regular night shifts. At the earliest, the implementation will begin in late September 2026 in three Finnish wellbeing services counties. Due to organizational decision-making and operational requirements, the intervention will be introduced at different time points (from September 2026 to early 2027) in different counties in a non-randomized manner using a staggered implementation design.

The participating organizations will modify shift schedules and staffing arrangements to accommodate the reduced working hours while ensuring continuity of services among those work units that have voluntarily decided to participate in the intervention. Control units consisting of matched work units will continue operating under the standard working-hour arrangement of 38 hours 15 minutes per week.

Data Sources The study will primarily utilize administrative, payroll-based, employer-owned working-hour data (see e.g., (Harma et al., 2015; Härmä et al., 2025; Ropponen et al., 2024)). The data will include day-to-day information on shift start and end times, shift duration, number of morning, day, evening and night shifts, number of consecutive shifts, weekend work, overtime hours, sickness absence (without any health or medical information), other absences and absence types (such as childcare or education), job title, work contracts and employment start and end dates. The data also includes information on organizational structure, including work units. The data will be processed both at the individual- and work unit-level as well as annual and scheduling-period summary measures.

Study Design The study will employ a non-randomized quasi-experimental design. The impact of the reduced working-hours (i.e., intervention) will be evaluated by comparing (1) changes before and during the implementation within intervention units, (2) changes between the intervention and the control units, and (3) changes across wellbeing services counties with different implementation schedules using a difference-in-differences framework (see, e.g., Turunen et al., 2020 and Turunen et al., 2025 for a similar approach in evaluating a participatory scheduling program implementation and national legislative change reducing the occurrence of quick returns, defined as rest periods of less than 11 hours between shifts, respectively).

The staggered introduction of the intervention across the three wellbeing services counties allows the use of longitudinal and difference-in-differences approaches to strengthen causal inference.

Baseline data will be collected from employer records before and during the implementation. Employer records will be available from the beginning of 2023 through the end of 2027, providing approximately 47 months of pre-intervention data and at least 15 months during the intervention, depending on the intervention start date in each county.

Tipo de estudo

Intervencional

Inscrição (Estimado)

200

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Locais de estudo

      • Kajaani, Finlândia
        • Kainuun hyvinvointialue
      • Lahti, Finlândia
        • Päijät-Hämeen hyvinvointialue
      • Oulu, Finlândia
        • Pohjois-Pohjanmaan hyvinvointialue

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos e mais velhos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Sim

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

Employment in one of the participating Finnish wellbeing services counties. Employees working in work units participating in the study. For the primary analyses, employees who work regular night shifts. Employees with available administrative, payroll-based working-hour and employment records.

Exclusion Criteria:

Exclusive day workers. Employees performing shift work that does not include night shifts. For the primary analyses, employees not engaged in regular night work.

Employees not performing regular night work may be included in secondary analyses evaluating workplace-level spillover effects.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Prevenção
  • Alocação: Não randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Reduced working hours (36 h)

Reduced working hours (36 h) for those who regularly conduct night shift work.

Reduced Working Hours (from 38h15minutes to 36h) for those conducting night shift work regularly

Sem intervenção: Standard working hours (38 h 15 min)

Standard working hours (38 h 15 min) for those whose organisation or unit did not choose to participate in the trial.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Sickness Absence Rate
Prazo: From enrollment to the end of treatment at 66 weeks.

Percentage of working time lost due to sickness absence, derived from administrative, payroll-based employer records. No medical or diagnostic information will be collected.

From enrollment to the end of treatment at 66 weeks.
Employee Turnover
Prazo: From enrollment to the end of treatment at 66 weeks.

Termination of employment during the follow-up period, derived from employment records.

From enrollment to the end of treatment at 66 weeks.
Retention of Employees Performing Night Work
Prazo: From enrollment to the end of treatment at 66 weeks.

Proportion of employees performing regular night work who remain employed and performing night shifts during the follow-up period.

From enrollment to the end of treatment at 66 weeks.
Total Weekly Working Hours
Prazo: From enrollment to the end of treatment at 66 weeks.

Average number of paid working hours per week, derived from administrative, payroll-based working-hour records.

From enrollment to the end of treatment at 66 weeks.
Number of Morning, Day, Evening, and Night Shifts
Prazo: From enrollment to the end of treatment at 66 weeks.

Number or rate of shifts worked during each scheduling period, categorized according to shift type (morning, day, evening, and night) using employer payroll-based working-hour records.

From enrollment to the end of treatment at 66 weeks.

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Number of Sickness Absence Episodes
Prazo: From enrollment to the end of treatment at 66 weeks.

Total number of sickness absence episodes recorded in administrative payroll-based employer records.

From enrollment to the end of treatment at 66 weeks.
Total Sickness Absence Days from Short Episodes (1-5 days) of Sickness Absence
Prazo: From enrollment to the end of treatment at 66 weeks.

Total number of sickness absence days from short episodes of sickness absence recorded in administrative payroll-based employer records.

From enrollment to the end of treatment at 66 weeks.
Short-Term Sickness Absence Episodes (1-5 Days)
Prazo: From enrollment to the end of treatment at 66 weeks.

Number of sickness absence episodes lasting 1-5 consecutive calendar days.

From enrollment to the end of treatment at 66 weeks.
Number of Consecutive Shifts
Prazo: From enrollment to the end of treatment at 66 weeks.

Number of instances in which employees work consecutive shifts without a day off, derived from administrative, payroll-based working-hour records.

From enrollment to the end of treatment at 66 weeks.
Overtime Hours
Prazo: From enrollment to the end of treatment at 66 weeks.

Total number of overtime hours worked during each scheduling period, derived from administrative, payroll-based working-hour records.

From enrollment to the end of treatment at 66 weeks.
Recovery Periods Between Shifts
Prazo: From enrollment to the end of treatment at 66 weeks.

Duration of rest periods between consecutive shifts, calculated from shift start and end times recorded in payroll-based working-hour data.

From enrollment to the end of treatment at 66 weeks.
Number of Quick Returns (<11 Hours Between Shifts)
Prazo: From enrollment to the end of treatment at 66 weeks.

Number of occurrences in which the interval between the end of one shift and the start of the next shift is less than 11 hours, derived from payroll-based working-hour records.

From enrollment to the end of treatment at 66 weeks.
Weekend Work
Prazo: From enrollment to the end of treatment at 66 weeks.

Number of shifts worked during weekends, derived from administrative, payroll-based working-hour records.

From enrollment to the end of treatment at 66 weeks.
Perceived Effects on Recovery
Prazo: From enrollment to the end of treatment at 66 weeks.

Employees', supervisors', shift planners', and managers' perceptions of the effects of the working-hour reduction on recovery from work, assessed using semi-structured interviews for focus group including employees, shift planners and management.

From enrollment to the end of treatment at 66 weeks.
Perceived Effects on Work-Life Balance
Prazo: From enrollment to the end of treatment at 66 weeks.

Participants' perceptions of the effects of the working-hour reduction on work-life balance, assessed using semi-structured interviews for focus group including employees, shift planners and management.

From enrollment to the end of treatment at 66 weeks.
Perceived Effects on Workload and Staffing
Prazo: From enrollment to the end of study at 66 weeks.

Participants' perceptions of the effects of the working-hour reduction on workload, staffing adequacy, and continuity of services, assessed using semi-structured interviews for focus group including employees, shift planners and management.

From enrollment to the end of study at 66 weeks.
Implementation Process
Prazo: From enrollment to the end of study at 66 weeks.

Experiences regarding the organization and implementation of the working-hour reduction, including facilitating factors and implementation challenges, assessed using semi-structured interviews for focus group including employees, shift planners and management.

From enrollment to the end of study at 66 weeks.
Perceived Advantages and Disadvantages of the Intervention
Prazo: From enrollment to the end of study at 66 weeks

Participants' views regarding positive consequences, unintended effects, challenges, and recommendations for future implementation of reduced working hours, assessed using semi-structured interviews for focus group including employees, shift planners and management.

From enrollment to the end of study at 66 weeks

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Colaboradores

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Publicações Gerais

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

30 de setembro de 2026

Conclusão Primária (Estimado)

28 de fevereiro de 2028

Conclusão do estudo (Estimado)

1 de abril de 2028

Datas de inscrição no estudo

Enviado pela primeira vez

17 de setembro de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

23 de setembro de 2026

Primeira postagem (Real)

30 de setembro de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

30 de setembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

23 de setembro de 2026

Última verificação

1 de setembro de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • WHRedu-36

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Descrição do plano IPD

Individual participant data will not be shared because the study uses employer-owned administrative and payroll-based records containing potentially identifiable employee information. Data sharing is restricted by data protection regulations, data use agreements, and organizational policies of the participating wellbeing services counties.

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .